Waystar Holding Corp. key statistics and ratios
In fiscal 2025, Waystar Holding Corp. had return on equity of 3.2%, an operating margin of 22.7%, debt equal to 38.2% of equity and a current ratio of 1.41. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|
| Operating margin | 12.7% | 18.0% | 13.1% | 22.7% | 21.9% |
| Net margin | −7.3% | −6.5% | −2.0% | 10.2% | 10.7% |
| Free-cash-flow margin | 12.1% | 3.8% | 15.1% | 25.8% | 20.9% |
| Return on equity | −2.4% | −2.5% | −0.7% | 3.2% | 3.4% |
| Return on assets | — | −1.1% | −0.4% | 2.2% | 2.3% |
| Asset turnover | — | 0.17 | 0.21 | 0.21 | 0.22 |
| Current ratio | — | 1.80 | 2.55 | 1.41 | 2.10 |
| Debt to equity | 0.0% | 109.7% | 40.4% | 38.2% | 36.4% |
| Effective tax rate | — | — | — | 34.7% | 30.4% |
| R&D as % of revenue | 4.7% | 4.5% | 5.2% | 5.0% | 5.9% |
| Capital spending as % of revenue | 2.5% | 2.7% | 2.9% | 2.4% | 4.0% |
| Free cash flow ÷ net income | — | — | — | 252.6% | 195.4% |
| Dividends and buybacks ÷ free cash flow | 2.9% | 2.3% | 0.6% | 0.0% | — |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | 21.8% | 25.4% | 24.0% | 22.4% | 19.4% | 25.6% | 23.8% | 18.8% |
| Net margin | 7.8% | 11.4% | 11.9% | 11.4% | 6.6% | 13.8% | 12.8% | 9.5% |
| Free-cash-flow margin | 24.0% | 22.9% | 33.6% | 28.3% | 18.9% | 22.2% | 13.5% | 28.9% |
| Current ratio | 2.55 | 3.12 | 3.43 | 3.89 | 1.41 | 1.76 | 1.85 | 2.10 |
| Debt to equity | 40.0% | 39.3% | 38.7% | 38.0% | 38.0% | 37.3% | 36.8% | 36.3% |
| R&D as % of revenue | 4.7% | 4.3% | 4.7% | 4.6% | 6.1% | 5.9% | 5.5% | 6.2% |
Financial health
- Short-term assets cover short-term liabilities $515m of assets due within a year against $245m of liabilities due within a year.
- Short-term assets cover long-term liabilities $515m short-term assets against $1.6bn of longer-dated liabilities.
- More cash than debt $31m of cash against $1.5bn of debt.
- Debt below 40% of shareholders' equity Debt is 36% of equity.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt $315m of operating cash flow against $1.5bn of debt.
- Operating profit covers interest at least five times over Interest not separately reported. Not assessable.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Compare with peers
- Omnicell, Inc. statistics
- Tempus AI, Inc. statistics
- Goodrx Holdings, Inc. statistics
- Doximity, Inc. statistics
- Teladoc Health, Inc. statistics
Head to head: OMCL vs WAYTEM vs WAYGDRX vs WAYTDOC vs WAY
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies